Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1), 27-36
- https://doi.org/10.1053/sonc.2002.31525
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- TUMOUR ANGIOGENESISThe Journal of Pathology, 1996
- Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology, 1995
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992
- Prevalence of aberrant expression of the epidermal growth factor receptor in human cancersBritish Medical Bulletin, 1991
- Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulationBiochemistry, 1990
- Epidermal growth factor.Journal of Biological Chemistry, 1990
- GROWTH FACTOR RECEPTOR TYROSINE KINASESAnnual Review of Biochemistry, 1988
- The epidermal growth factor receptor as a multifunctional allosteric proteinBiochemistry, 1988
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987
- Epidermal Growth FactorAnnual Review of Biochemistry, 1979